Susquehanna Fundamental Investments, LLC Enanta Pharmaceuticals Inc Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $53,505 - $78,967	-1,108 Reduced 14.97%	6,291 $326,000
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $34,757 - $45,948	620 Added 9.15%	7,399 $527,000
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $157,095 - $254,135	2,610 Added 62.6%	6,779 $507,000
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $184,384 - $263,631	-4,495 Reduced 51.88%	4,169 $237,000
Q2 2021 Aug 11, 2021	BUY	$43.76 - $53.11 $116,051 - $140,847	2,652 Added 44.11%	8,664 $381,000
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $250,640 - $330,359	6,012 New	6,012 $297,000
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $687,289 - $792,654	-16,698 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $226,252 - $279,319	-5,218 Reduced 23.81%	16,698 $764,000
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $1.02 Million - $1.26 Million	21,916 New	21,916 $1.1 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.